TRAVERE THERAPEUTICS INC - NOTE 2.250% 3/0

Q3 2023 13F Holders as of 9/30/2023

Type / Class
Debt / NOTE 2.250% 3/0
Number of holders
22
Total Principal
294M
Shares change
-8.49M
Total reported value, excl. options
$216M
Value change
+$1.58M
Put/Call ratio
0
Number of buys
9
Number of sells
-9
Price
$0.65
Investor Option Weight % Change % Value $ * Price $ Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.